HomeNGNE • NASDAQ
add
Neurogene Inc
Previous close
$48.15
Day range
$47.81 - $50.13
Year range
$12.49 - $52.74
Market cap
642.27M USD
Avg Volume
122.10K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 925.00K | — |
Operating expense | 5.32M | 133.63% |
Net income | -18.49M | -55.92% |
Net profit margin | -2.00K | — |
Earnings per share | — | — |
EBITDA | -19.32M | -64.08% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 153.90M | 160.64% |
Total assets | 179.82M | 109.60% |
Total liabilities | 24.81M | 136.70% |
Total equity | 155.01M | — |
Shares outstanding | 12.99M | — |
Price to book | 4.04 | — |
Return on assets | -26.83% | — |
Return on capital | -28.44% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -18.49M | -55.92% |
Cash from operations | -15.89M | -70.40% |
Cash from investing | -23.61M | -28,697.56% |
Cash from financing | 399.00K | 563.95% |
Net change in cash | -39.11M | -311.88% |
Free cash flow | -9.40M | — |
About
Founded
2018
Website
Employees
91